Tumor microenvironment immunotherapy: Transforming cancer treatment and immune checkpoint inhibitors - Future directions and challenges
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-06-01
|
| Series: | Oral Oncology Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772906024002371 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841553693937238016 |
|---|---|
| author | Jeeva Jothi Kumaravel Geetha Anbalagan Dilipan Elangovan Muthamizh Selvamani Balachandran Subramanian |
| author_facet | Jeeva Jothi Kumaravel Geetha Anbalagan Dilipan Elangovan Muthamizh Selvamani Balachandran Subramanian |
| author_sort | Jeeva Jothi Kumaravel |
| collection | DOAJ |
| format | Article |
| id | doaj-art-b63808a344c948ad8d7c31cb8d8801b3 |
| institution | Kabale University |
| issn | 2772-9060 |
| language | English |
| publishDate | 2024-06-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Oral Oncology Reports |
| spelling | doaj-art-b63808a344c948ad8d7c31cb8d8801b32025-01-09T06:16:03ZengElsevierOral Oncology Reports2772-90602024-06-0110100391Tumor microenvironment immunotherapy: Transforming cancer treatment and immune checkpoint inhibitors - Future directions and challengesJeeva Jothi Kumaravel0Geetha Anbalagan1Dilipan Elangovan2Muthamizh Selvamani3Balachandran Subramanian4Department of Physiology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Science (SIMATS), Saveetha University, Chennai, IndiaDepartment of Physiology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Science (SIMATS), Saveetha University, Chennai, IndiaDepartment of Physiology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Science (SIMATS), Saveetha University, Chennai, IndiaDepartment of Physiology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Science (SIMATS), Saveetha University, Chennai, IndiaCorresponding author.; Department of Physiology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Science (SIMATS), Saveetha University, Chennai, Indiahttp://www.sciencedirect.com/science/article/pii/S2772906024002371 |
| spellingShingle | Jeeva Jothi Kumaravel Geetha Anbalagan Dilipan Elangovan Muthamizh Selvamani Balachandran Subramanian Tumor microenvironment immunotherapy: Transforming cancer treatment and immune checkpoint inhibitors - Future directions and challenges Oral Oncology Reports |
| title | Tumor microenvironment immunotherapy: Transforming cancer treatment and immune checkpoint inhibitors - Future directions and challenges |
| title_full | Tumor microenvironment immunotherapy: Transforming cancer treatment and immune checkpoint inhibitors - Future directions and challenges |
| title_fullStr | Tumor microenvironment immunotherapy: Transforming cancer treatment and immune checkpoint inhibitors - Future directions and challenges |
| title_full_unstemmed | Tumor microenvironment immunotherapy: Transforming cancer treatment and immune checkpoint inhibitors - Future directions and challenges |
| title_short | Tumor microenvironment immunotherapy: Transforming cancer treatment and immune checkpoint inhibitors - Future directions and challenges |
| title_sort | tumor microenvironment immunotherapy transforming cancer treatment and immune checkpoint inhibitors future directions and challenges |
| url | http://www.sciencedirect.com/science/article/pii/S2772906024002371 |
| work_keys_str_mv | AT jeevajothikumaravel tumormicroenvironmentimmunotherapytransformingcancertreatmentandimmunecheckpointinhibitorsfuturedirectionsandchallenges AT geethaanbalagan tumormicroenvironmentimmunotherapytransformingcancertreatmentandimmunecheckpointinhibitorsfuturedirectionsandchallenges AT dilipanelangovan tumormicroenvironmentimmunotherapytransformingcancertreatmentandimmunecheckpointinhibitorsfuturedirectionsandchallenges AT muthamizhselvamani tumormicroenvironmentimmunotherapytransformingcancertreatmentandimmunecheckpointinhibitorsfuturedirectionsandchallenges AT balachandransubramanian tumormicroenvironmentimmunotherapytransformingcancertreatmentandimmunecheckpointinhibitorsfuturedirectionsandchallenges |